Log In
Print
BCIQ
Print
Print this Print this
 

Kyprolis, carfilzomib (ONO-7057, PR-171)

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionSelective proteasome inhibitor
Molecular Target Proteasome
Mechanism of ActionProteasome inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today